Printer friendly version Share

News Release

Muscle, skin and gastrointestinal problems cause a quarter of patients with heart disease and strokes to stop treatment in HPS2-THRIVE trial

25 February 2013 European Society of Cardiology (ESC)

Please login or register to view articles older than 3 months

Cambridge blue millet expertsvar 2015 Elhuyar with Basque eNEWS6 FNSF ad New Norwegian logo Facebook 2015